Skip to main content Skip to footer
Nighthawk Biosciences, Inc.
  • Home
  • About
    • Management Team
    • Board of Directors
  • Scorpius Biomanufacturing
  • Investors & News
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Info
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Info
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
      • Analyst Coverage
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
    • Corporate Presentation
  • Contact

Press Releases

Investors & News

Investors & News

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Corporate Presentation
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts
Jul 22, 2016 8:00am EDT

Heat Biologics Announces Suspension of Proposed Public Offering of Common Stock

Jul 21, 2016 4:15pm EDT

Heat Biologics Announces Proposed Public Offering of Common Stock

Jul 07, 2016 7:00am EDT

Heat Biologics Announces “Cancer Immunology Research” Publication Featuring its ComPACT Platform Technology

Jun 06, 2016 7:00am EDT

Heat Biologics Presents a Poster on its HS-110/Nivolumab Combination Phase 1b Non-Small Cell Lung Cancer Trial at ASCO Annual Meeting

May 11, 2016 7:00am EDT

Heat Biologics Reports First Quarter 2016 Financial Results

Apr 26, 2016 7:00am EDT

Heat Biologics to Present at PIONEERS 2016, Presented by Joseph Gunnar & Co.

Apr 25, 2016 7:00am EDT

Heat Biologics Appoints Dr. John Prendergast to Board of Directors

Apr 18, 2016 6:00am EDT

Heat Biologics and OncoSec Present Data at the American Conference for Cancer Research (AACR) Annual Meeting

Apr 12, 2016 6:00am EDT

Heat Biologics to Present at the American Association for Cancer Research (AACR) Annual Meeting

Apr 07, 2016 7:00am EDT

Heat Biologics Announces Cost-Saving Measures and Focused Corporate Strategy to Achieve Important Clinical Milestones

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 17
  • Page 18
  • Page 19
  • Page 20
  • Page 21
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Page 26
  • …
  • Page 31
  • Next Pagearrow_forward
rss_feed News RSS
NightHawk Biosciences
  • Email Alerts
  • Contacts
  • RSS News Feed
©2024 Nighthawk Biosciences, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap
  • Visit us on LinkedIn
  • Visit us on Twitter
  • Visit us on YouTube
  • Visit us on Facebook

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.